nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MT3—lung cancer	0.399	0.865	CbGaD
Melatonin—CYP1A1—lung cancer	0.0621	0.134	CbGaD
Melatonin—MPO—Cisplatin—lung cancer	0.0378	0.134	CbGbCtD
Melatonin—CYP1B1—Erlotinib—lung cancer	0.0341	0.121	CbGbCtD
Melatonin—CYP1B1—Paclitaxel—lung cancer	0.0312	0.11	CbGbCtD
Melatonin—CYP1A1—Gefitinib—lung cancer	0.0253	0.0895	CbGbCtD
Melatonin—CYP19A1—Paclitaxel—lung cancer	0.0253	0.0895	CbGbCtD
Melatonin—CYP1B1—Docetaxel—lung cancer	0.0226	0.0798	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—lung cancer	0.0168	0.0595	CbGbCtD
Melatonin—CYP1A1—Erlotinib—lung cancer	0.015	0.0529	CbGbCtD
Melatonin—CYP2C19—Gefitinib—lung cancer	0.0123	0.0433	CbGbCtD
Melatonin—CYP2C19—Teniposide—lung cancer	0.0119	0.042	CbGbCtD
Melatonin—CYP2C9—Gefitinib—lung cancer	0.0102	0.036	CbGbCtD
Melatonin—CYP2C9—Teniposide—lung cancer	0.00989	0.0349	CbGbCtD
Melatonin—SLC22A8—Methotrexate—lung cancer	0.00901	0.0318	CbGbCtD
Melatonin—CYP1A2—Erlotinib—lung cancer	0.00669	0.0236	CbGbCtD
Melatonin—CYP2C9—Paclitaxel—lung cancer	0.00552	0.0195	CbGbCtD
Melatonin—CYP1A2—Etoposide—lung cancer	0.00484	0.0171	CbGbCtD
Melatonin—CYP2C9—Cisplatin—lung cancer	0.00444	0.0157	CbGbCtD
Melatonin—EPX—respiratory system—lung cancer	0.00342	0.0748	CbGeAlD
Melatonin—IDO1—respiratory system—lung cancer	0.00259	0.0567	CbGeAlD
Melatonin—CALR—mammary gland—lung cancer	0.00228	0.0499	CbGeAlD
Melatonin—EPX—bone marrow—lung cancer	0.002	0.0438	CbGeAlD
Melatonin—EPX—lung—lung cancer	0.00182	0.0397	CbGeAlD
Melatonin—CALR—respiratory system—lung cancer	0.00152	0.0332	CbGeAlD
Melatonin—IDO1—lung—lung cancer	0.00138	0.0301	CbGeAlD
Melatonin—CALR—epithelium—lung cancer	0.00127	0.0278	CbGeAlD
Melatonin—CALR—bronchus—lung cancer	0.00125	0.0274	CbGeAlD
Melatonin—CALR—trachea—lung cancer	0.00112	0.0246	CbGeAlD
Melatonin—CALR—cardiac atrium—lung cancer	0.00105	0.0231	CbGeAlD
Melatonin—MT3—lung—lung cancer	0.00102	0.0224	CbGeAlD
Melatonin—IDO1—lymph node—lung cancer	0.000941	0.0206	CbGeAlD
Melatonin—CALR—bone marrow—lung cancer	0.00089	0.0195	CbGeAlD
Melatonin—CALM3—mammary gland—lung cancer	0.00089	0.0195	CbGeAlD
Melatonin—CALR—lung—lung cancer	0.000807	0.0176	CbGeAlD
Melatonin—CYP1B1—mammary gland—lung cancer	0.000756	0.0165	CbGeAlD
Melatonin—NQO2—bronchus—lung cancer	0.000705	0.0154	CbGeAlD
Melatonin—ESR1—mammary gland—lung cancer	0.000703	0.0154	CbGeAlD
Melatonin—MT3—lymph node—lung cancer	0.000699	0.0153	CbGeAlD
Melatonin—CALM1—mammary gland—lung cancer	0.000695	0.0152	CbGeAlD
Melatonin—MPO—respiratory system—lung cancer	0.00066	0.0144	CbGeAlD
Melatonin—NQO2—trachea—lung cancer	0.000633	0.0139	CbGeAlD
Melatonin—NQO2—cardiac atrium—lung cancer	0.000595	0.013	CbGeAlD
Melatonin—CALR—lymph node—lung cancer	0.000552	0.0121	CbGeAlD
Melatonin—MPO—epithelium—lung cancer	0.000551	0.0121	CbGeAlD
Melatonin—CYP2C9—mammary gland—lung cancer	0.000514	0.0113	CbGeAlD
Melatonin—CYP1B1—respiratory system—lung cancer	0.000504	0.011	CbGeAlD
Melatonin—NQO2—bone marrow—lung cancer	0.000502	0.011	CbGeAlD
Melatonin—CALM3—bronchus—lung cancer	0.000488	0.0107	CbGeAlD
Melatonin—ESR1—respiratory system—lung cancer	0.000468	0.0102	CbGeAlD
Melatonin—CALM2—respiratory system—lung cancer	0.000466	0.0102	CbGeAlD
Melatonin—CALM1—respiratory system—lung cancer	0.000463	0.0101	CbGeAlD
Melatonin—NQO2—lung—lung cancer	0.000455	0.00995	CbGeAlD
Melatonin—CALM3—trachea—lung cancer	0.000438	0.00958	CbGeAlD
Melatonin—CALM3—cardiac atrium—lung cancer	0.000412	0.009	CbGeAlD
Melatonin—ESR1—epithelium—lung cancer	0.000391	0.00856	CbGeAlD
Melatonin—CALM2—epithelium—lung cancer	0.000389	0.00851	CbGeAlD
Melatonin—CALM1—epithelium—lung cancer	0.000387	0.00847	CbGeAlD
Melatonin—MPO—bone marrow—lung cancer	0.000387	0.00846	CbGeAlD
Melatonin—CALM2—bronchus—lung cancer	0.000383	0.00838	CbGeAlD
Melatonin—CALM1—bronchus—lung cancer	0.000381	0.00834	CbGeAlD
Melatonin—Sumatriptan—ABCG2—lung cancer	0.000369	0.322	CrCbGaD
Melatonin—CYP1A2—respiratory system—lung cancer	0.000361	0.0079	CbGeAlD
Melatonin—CYP1A1—respiratory system—lung cancer	0.000356	0.00779	CbGeAlD
Melatonin—MPO—lung—lung cancer	0.00035	0.00766	CbGeAlD
Melatonin—CALM3—bone marrow—lung cancer	0.000347	0.0076	CbGeAlD
Melatonin—CALM2—trachea—lung cancer	0.000344	0.00753	CbGeAlD
Melatonin—CALM1—trachea—lung cancer	0.000342	0.00749	CbGeAlD
Melatonin—CALM2—cardiac atrium—lung cancer	0.000323	0.00707	CbGeAlD
Melatonin—CALM1—cardiac atrium—lung cancer	0.000322	0.00704	CbGeAlD
Melatonin—Nabumetone—PTGS2—lung cancer	0.000319	0.278	CrCbGaD
Melatonin—CALM3—lung—lung cancer	0.000315	0.00689	CbGeAlD
Melatonin—NQO2—lymph node—lung cancer	0.000311	0.00681	CbGeAlD
Melatonin—Almotriptan—CYP2E1—lung cancer	0.000304	0.266	CrCbGaD
Melatonin—CYP1A1—epithelium—lung cancer	0.000298	0.00651	CbGeAlD
Melatonin—CYP1A1—bronchus—lung cancer	0.000293	0.00641	CbGeAlD
Melatonin—CALM2—bone marrow—lung cancer	0.000273	0.00597	CbGeAlD
Melatonin—CALM1—bone marrow—lung cancer	0.000272	0.00594	CbGeAlD
Melatonin—CYP1B1—lung—lung cancer	0.000268	0.00585	CbGeAlD
Melatonin—CYP1A1—trachea—lung cancer	0.000263	0.00576	CbGeAlD
Melatonin—ESR1—lung—lung cancer	0.000249	0.00544	CbGeAlD
Melatonin—CYP1A1—cardiac atrium—lung cancer	0.000247	0.00541	CbGeAlD
Melatonin—CALM2—lung—lung cancer	0.000247	0.00541	CbGeAlD
Melatonin—CALM1—lung—lung cancer	0.000246	0.00538	CbGeAlD
Melatonin—MPO—lymph node—lung cancer	0.00024	0.00524	CbGeAlD
Melatonin—CALM3—lymph node—lung cancer	0.000215	0.00471	CbGeAlD
Melatonin—CYP19A1—lymph node—lung cancer	0.000196	0.00428	CbGeAlD
Melatonin—CYP1A2—lung—lung cancer	0.000192	0.00419	CbGeAlD
Melatonin—CYP1A1—lung—lung cancer	0.000189	0.00414	CbGeAlD
Melatonin—CYP1B1—lymph node—lung cancer	0.000183	0.004	CbGeAlD
Melatonin—ESR1—lymph node—lung cancer	0.00017	0.00372	CbGeAlD
Melatonin—CALM2—lymph node—lung cancer	0.000169	0.0037	CbGeAlD
Melatonin—CALM1—lymph node—lung cancer	0.000168	0.00368	CbGeAlD
Melatonin—Sumatriptan—ABCB1—lung cancer	0.000154	0.134	CrCbGaD
Melatonin—CYP1A1—lymph node—lung cancer	0.000129	0.00283	CbGeAlD
Melatonin—Loss of consciousness—Paclitaxel—lung cancer	8.23e-05	0.000871	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—lung cancer	8.22e-05	0.00087	CcSEcCtD
Melatonin—Paraesthesia—Gemcitabine—lung cancer	8.19e-05	0.000867	CcSEcCtD
Melatonin—Asthenia—Vinorelbine—lung cancer	8.15e-05	0.000862	CcSEcCtD
Melatonin—Chest pain—Etoposide—lung cancer	8.13e-05	0.00086	CcSEcCtD
Melatonin—Nausea—Vinblastine—lung cancer	8.12e-05	0.000859	CcSEcCtD
Melatonin—Somnolence—Gemcitabine—lung cancer	8.11e-05	0.000858	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—lung cancer	8.09e-05	0.000856	CcSEcCtD
Melatonin—Migraine—Doxorubicin—lung cancer	8.09e-05	0.000856	CcSEcCtD
Melatonin—Gastrointestinal disorder—Irinotecan—lung cancer	8.09e-05	0.000856	CcSEcCtD
Melatonin—Hypertension—Paclitaxel—lung cancer	8.08e-05	0.000855	CcSEcCtD
Melatonin—Fatigue—Irinotecan—lung cancer	8.08e-05	0.000855	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	8.07e-05	0.000854	CcSEcCtD
Melatonin—Pruritus—Vinorelbine—lung cancer	8.04e-05	0.00085	CcSEcCtD
Melatonin—Pain—Irinotecan—lung cancer	8.01e-05	0.000848	CcSEcCtD
Melatonin—Mental disorder—Docetaxel—lung cancer	7.99e-05	0.000845	CcSEcCtD
Melatonin—Arthralgia—Paclitaxel—lung cancer	7.97e-05	0.000843	CcSEcCtD
Melatonin—Chest pain—Paclitaxel—lung cancer	7.97e-05	0.000843	CcSEcCtD
Melatonin—Anxiety—Paclitaxel—lung cancer	7.94e-05	0.00084	CcSEcCtD
Melatonin—Erythema—Docetaxel—lung cancer	7.94e-05	0.00084	CcSEcCtD
Melatonin—Malnutrition—Docetaxel—lung cancer	7.94e-05	0.00084	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	7.92e-05	0.000838	CcSEcCtD
Melatonin—Nausea—Topotecan—lung cancer	7.89e-05	0.000835	CcSEcCtD
Melatonin—Gastrointestinal disorder—Gemcitabine—lung cancer	7.88e-05	0.000834	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—lung cancer	7.87e-05	0.000833	CcSEcCtD
Melatonin—Fatigue—Gemcitabine—lung cancer	7.87e-05	0.000833	CcSEcCtD
Melatonin—Pain—Gemcitabine—lung cancer	7.8e-05	0.000826	CcSEcCtD
Melatonin—Nausea—Erlotinib—lung cancer	7.8e-05	0.000826	CcSEcCtD
Melatonin—Dry mouth—Paclitaxel—lung cancer	7.8e-05	0.000825	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—lung cancer	7.79e-05	0.000824	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Cisplatin—lung cancer	7.75e-05	0.00082	CcSEcCtD
Melatonin—Infection—Etoposide—lung cancer	7.74e-05	0.000819	CcSEcCtD
Melatonin—Back pain—Docetaxel—lung cancer	7.68e-05	0.000812	CcSEcCtD
Melatonin—Gastrointestinal pain—Irinotecan—lung cancer	7.66e-05	0.000811	CcSEcCtD
Melatonin—Paraesthesia—Cisplatin—lung cancer	7.64e-05	0.000808	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—lung cancer	7.63e-05	0.000807	CcSEcCtD
Melatonin—Muscle spasms—Docetaxel—lung cancer	7.63e-05	0.000807	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—lung cancer	7.59e-05	0.000803	CcSEcCtD
Melatonin—Infection—Paclitaxel—lung cancer	7.59e-05	0.000803	CcSEcCtD
Melatonin—Skin disorder—Etoposide—lung cancer	7.57e-05	0.000801	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—lung cancer	7.54e-05	0.000798	CcSEcCtD
Melatonin—Shock—Paclitaxel—lung cancer	7.52e-05	0.000795	CcSEcCtD
Melatonin—Dizziness—Vinorelbine—lung cancer	7.51e-05	0.000795	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—lung cancer	7.51e-05	0.000795	CcSEcCtD
Melatonin—Nervous system disorder—Paclitaxel—lung cancer	7.49e-05	0.000793	CcSEcCtD
Melatonin—Thrombocytopenia—Paclitaxel—lung cancer	7.48e-05	0.000792	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—lung cancer	7.43e-05	0.000786	CcSEcCtD
Melatonin—Skin disorder—Paclitaxel—lung cancer	7.42e-05	0.000785	CcSEcCtD
Melatonin—Abdominal pain—Irinotecan—lung cancer	7.41e-05	0.000784	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—lung cancer	7.35e-05	0.000778	CcSEcCtD
Melatonin—Gastrointestinal disorder—Cisplatin—lung cancer	7.34e-05	0.000777	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—lung cancer	7.32e-05	0.000774	CcSEcCtD
Melatonin—Infestation—Methotrexate—lung cancer	7.32e-05	0.000774	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—lung cancer	7.28e-05	0.00077	CcSEcCtD
Melatonin—Pain—Cisplatin—lung cancer	7.27e-05	0.00077	CcSEcCtD
Melatonin—Vomiting—Vinorelbine—lung cancer	7.22e-05	0.000764	CcSEcCtD
Melatonin—Rash—Vinorelbine—lung cancer	7.16e-05	0.000758	CcSEcCtD
Melatonin—Dermatitis—Vinorelbine—lung cancer	7.16e-05	0.000757	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—lung cancer	7.13e-05	0.000755	CcSEcCtD
Melatonin—Headache—Vinorelbine—lung cancer	7.12e-05	0.000753	CcSEcCtD
Melatonin—Syncope—Docetaxel—lung cancer	7.12e-05	0.000753	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—lung cancer	7.1e-05	0.000752	CcSEcCtD
Melatonin—Palpitations—Docetaxel—lung cancer	7.01e-05	0.000742	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—lung cancer	7e-05	0.00074	CcSEcCtD
Melatonin—Haematuria—Methotrexate—lung cancer	6.98e-05	0.000738	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—lung cancer	6.97e-05	0.000738	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.96e-05	0.000737	CcSEcCtD
Melatonin—Somnolence—Etoposide—lung cancer	6.93e-05	0.000733	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—lung cancer	6.92e-05	0.000733	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—lung cancer	6.92e-05	0.000732	CcSEcCtD
Melatonin—Insomnia—Paclitaxel—lung cancer	6.91e-05	0.000731	CcSEcCtD
Melatonin—Hypersensitivity—Irinotecan—lung cancer	6.9e-05	0.00073	CcSEcCtD
Melatonin—Paraesthesia—Paclitaxel—lung cancer	6.86e-05	0.000726	CcSEcCtD
Melatonin—Hypertension—Docetaxel—lung cancer	6.85e-05	0.000725	CcSEcCtD
Melatonin—Somnolence—Paclitaxel—lung cancer	6.79e-05	0.000719	CcSEcCtD
Melatonin—Chest pain—Docetaxel—lung cancer	6.76e-05	0.000715	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—lung cancer	6.76e-05	0.000715	CcSEcCtD
Melatonin—Nausea—Vinorelbine—lung cancer	6.75e-05	0.000714	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—lung cancer	6.73e-05	0.000712	CcSEcCtD
Melatonin—Dyspepsia—Paclitaxel—lung cancer	6.73e-05	0.000712	CcSEcCtD
Melatonin—Asthenia—Irinotecan—lung cancer	6.72e-05	0.000711	CcSEcCtD
Melatonin—Fatigue—Etoposide—lung cancer	6.72e-05	0.000711	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	6.71e-05	0.00071	CcSEcCtD
Melatonin—Pain—Etoposide—lung cancer	6.66e-05	0.000705	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—lung cancer	6.61e-05	0.000699	CcSEcCtD
Melatonin—Gastrointestinal disorder—Paclitaxel—lung cancer	6.6e-05	0.000698	CcSEcCtD
Melatonin—Fatigue—Paclitaxel—lung cancer	6.59e-05	0.000697	CcSEcCtD
Melatonin—Asthenia—Gemcitabine—lung cancer	6.55e-05	0.000693	CcSEcCtD
Melatonin—Pain—Paclitaxel—lung cancer	6.53e-05	0.000691	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—lung cancer	6.49e-05	0.000687	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—lung cancer	6.47e-05	0.000684	CcSEcCtD
Melatonin—Pruritus—Gemcitabine—lung cancer	6.46e-05	0.000683	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—lung cancer	6.44e-05	0.000681	CcSEcCtD
Melatonin—Infection—Docetaxel—lung cancer	6.43e-05	0.000681	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—lung cancer	6.37e-05	0.000674	CcSEcCtD
Melatonin—Shock—Docetaxel—lung cancer	6.37e-05	0.000674	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—lung cancer	6.35e-05	0.000672	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—lung cancer	6.34e-05	0.000671	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—lung cancer	6.34e-05	0.000671	CcSEcCtD
Melatonin—Infestation—Doxorubicin—lung cancer	6.34e-05	0.000671	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—lung cancer	6.29e-05	0.000666	CcSEcCtD
Melatonin—Hypersensitivity—Cisplatin—lung cancer	6.27e-05	0.000663	CcSEcCtD
Melatonin—Gastrointestinal pain—Paclitaxel—lung cancer	6.25e-05	0.000661	CcSEcCtD
Melatonin—Dizziness—Irinotecan—lung cancer	6.2e-05	0.000656	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—lung cancer	6.18e-05	0.000654	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—lung cancer	6.16e-05	0.000652	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—lung cancer	6.14e-05	0.00065	CcSEcCtD
Melatonin—Asthenia—Cisplatin—lung cancer	6.1e-05	0.000646	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—lung cancer	6.1e-05	0.000645	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—lung cancer	6.04e-05	0.000639	CcSEcCtD
Melatonin—Abdominal pain—Paclitaxel—lung cancer	6.04e-05	0.000639	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—lung cancer	5.99e-05	0.000634	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—lung cancer	5.96e-05	0.000631	CcSEcCtD
Melatonin—Vomiting—Irinotecan—lung cancer	5.96e-05	0.00063	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—lung cancer	5.93e-05	0.000628	CcSEcCtD
Melatonin—Rash—Irinotecan—lung cancer	5.91e-05	0.000625	CcSEcCtD
Melatonin—Dermatitis—Irinotecan—lung cancer	5.9e-05	0.000624	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—lung cancer	5.9e-05	0.000624	CcSEcCtD
Melatonin—Headache—Irinotecan—lung cancer	5.87e-05	0.000621	CcSEcCtD
Melatonin—Insomnia—Docetaxel—lung cancer	5.86e-05	0.00062	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—lung cancer	5.82e-05	0.000615	CcSEcCtD
Melatonin—Vomiting—Gemcitabine—lung cancer	5.8e-05	0.000614	CcSEcCtD
Melatonin—Somnolence—Docetaxel—lung cancer	5.76e-05	0.000609	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—lung cancer	5.76e-05	0.000609	CcSEcCtD
Melatonin—Rash—Gemcitabine—lung cancer	5.75e-05	0.000609	CcSEcCtD
Melatonin—Dermatitis—Gemcitabine—lung cancer	5.75e-05	0.000608	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—lung cancer	5.74e-05	0.000608	CcSEcCtD
Melatonin—Erythema—Methotrexate—lung cancer	5.72e-05	0.000605	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—lung cancer	5.72e-05	0.000605	CcSEcCtD
Melatonin—Headache—Gemcitabine—lung cancer	5.72e-05	0.000605	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—lung cancer	5.7e-05	0.000603	CcSEcCtD
Melatonin—Hypersensitivity—Paclitaxel—lung cancer	5.63e-05	0.000596	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—lung cancer	5.62e-05	0.000594	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—lung cancer	5.59e-05	0.000592	CcSEcCtD
Melatonin—Asthenia—Etoposide—lung cancer	5.59e-05	0.000592	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—lung cancer	5.59e-05	0.000592	CcSEcCtD
Melatonin—Fatigue—Docetaxel—lung cancer	5.58e-05	0.000591	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—lung cancer	5.58e-05	0.00059	CcSEcCtD
Melatonin—Nausea—Irinotecan—lung cancer	5.56e-05	0.000589	CcSEcCtD
Melatonin—Pain—Docetaxel—lung cancer	5.54e-05	0.000586	CcSEcCtD
Melatonin—Back pain—Methotrexate—lung cancer	5.53e-05	0.000585	CcSEcCtD
Melatonin—Pruritus—Etoposide—lung cancer	5.51e-05	0.000583	CcSEcCtD
Melatonin—Asthenia—Paclitaxel—lung cancer	5.48e-05	0.00058	CcSEcCtD
Melatonin—Nausea—Gemcitabine—lung cancer	5.42e-05	0.000574	CcSEcCtD
Melatonin—Vomiting—Cisplatin—lung cancer	5.41e-05	0.000572	CcSEcCtD
Melatonin—Pruritus—Paclitaxel—lung cancer	5.41e-05	0.000572	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—lung cancer	5.39e-05	0.00057	CcSEcCtD
Melatonin—Rash—Cisplatin—lung cancer	5.36e-05	0.000567	CcSEcCtD
Melatonin—Dermatitis—Cisplatin—lung cancer	5.36e-05	0.000567	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—lung cancer	5.32e-05	0.000563	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—lung cancer	5.3e-05	0.00056	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—lung cancer	5.28e-05	0.000559	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—lung cancer	5.16e-05	0.000546	CcSEcCtD
Melatonin—Dizziness—Etoposide—lung cancer	5.15e-05	0.000545	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—lung cancer	5.14e-05	0.000544	CcSEcCtD
Melatonin—Vertigo—Methotrexate—lung cancer	5.14e-05	0.000544	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—lung cancer	5.12e-05	0.000542	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—lung cancer	5.12e-05	0.000542	CcSEcCtD
Melatonin—Dizziness—Paclitaxel—lung cancer	5.05e-05	0.000535	CcSEcCtD
Melatonin—Nausea—Cisplatin—lung cancer	5.05e-05	0.000535	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—lung cancer	4.98e-05	0.000527	CcSEcCtD
Melatonin—Vomiting—Etoposide—lung cancer	4.95e-05	0.000524	CcSEcCtD
Melatonin—Erythema—Doxorubicin—lung cancer	4.95e-05	0.000524	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—lung cancer	4.95e-05	0.000524	CcSEcCtD
Melatonin—Rash—Etoposide—lung cancer	4.91e-05	0.00052	CcSEcCtD
Melatonin—Dermatitis—Etoposide—lung cancer	4.91e-05	0.000519	CcSEcCtD
Melatonin—Headache—Etoposide—lung cancer	4.88e-05	0.000517	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—lung cancer	4.88e-05	0.000516	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—lung cancer	4.87e-05	0.000515	CcSEcCtD
Melatonin—Chest pain—Methotrexate—lung cancer	4.87e-05	0.000515	CcSEcCtD
Melatonin—Tension—Doxorubicin—lung cancer	4.86e-05	0.000514	CcSEcCtD
Melatonin—Vomiting—Paclitaxel—lung cancer	4.86e-05	0.000514	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.84e-05	0.000512	CcSEcCtD
Melatonin—Rash—Paclitaxel—lung cancer	4.82e-05	0.00051	CcSEcCtD
Melatonin—Dermatitis—Paclitaxel—lung cancer	4.81e-05	0.000509	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—lung cancer	4.81e-05	0.000509	CcSEcCtD
Melatonin—Back pain—Doxorubicin—lung cancer	4.79e-05	0.000507	CcSEcCtD
Melatonin—Headache—Paclitaxel—lung cancer	4.79e-05	0.000506	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—lung cancer	4.77e-05	0.000505	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—lung cancer	4.76e-05	0.000504	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—lung cancer	4.67e-05	0.000494	CcSEcCtD
Melatonin—Asthenia—Docetaxel—lung cancer	4.65e-05	0.000492	CcSEcCtD
Melatonin—Infection—Methotrexate—lung cancer	4.64e-05	0.000491	CcSEcCtD
Melatonin—Nausea—Etoposide—lung cancer	4.63e-05	0.00049	CcSEcCtD
Melatonin—Pruritus—Docetaxel—lung cancer	4.58e-05	0.000485	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—lung cancer	4.58e-05	0.000484	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—lung cancer	4.57e-05	0.000484	CcSEcCtD
Melatonin—Agitation—Doxorubicin—lung cancer	4.55e-05	0.000482	CcSEcCtD
Melatonin—Nausea—Paclitaxel—lung cancer	4.54e-05	0.00048	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—lung cancer	4.53e-05	0.00048	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—lung cancer	4.45e-05	0.000471	CcSEcCtD
Melatonin—Syncope—Doxorubicin—lung cancer	4.44e-05	0.00047	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—lung cancer	4.43e-05	0.000469	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—lung cancer	4.38e-05	0.000463	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—lung cancer	4.35e-05	0.000461	CcSEcCtD
Melatonin—Dizziness—Docetaxel—lung cancer	4.28e-05	0.000453	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—lung cancer	4.28e-05	0.000452	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—lung cancer	4.25e-05	0.00045	CcSEcCtD
Melatonin—Insomnia—Methotrexate—lung cancer	4.22e-05	0.000447	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—lung cancer	4.22e-05	0.000446	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—lung cancer	4.22e-05	0.000446	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—lung cancer	4.2e-05	0.000445	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—lung cancer	4.19e-05	0.000443	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.19e-05	0.000443	CcSEcCtD
Melatonin—Somnolence—Methotrexate—lung cancer	4.15e-05	0.000439	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—lung cancer	4.12e-05	0.000436	CcSEcCtD
Melatonin—Vomiting—Docetaxel—lung cancer	4.12e-05	0.000436	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—lung cancer	4.11e-05	0.000435	CcSEcCtD
Melatonin—Rash—Docetaxel—lung cancer	4.08e-05	0.000432	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—lung cancer	4.08e-05	0.000432	CcSEcCtD
Melatonin—Headache—Docetaxel—lung cancer	4.06e-05	0.000429	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—lung cancer	4.03e-05	0.000426	CcSEcCtD
Melatonin—Fatigue—Methotrexate—lung cancer	4.02e-05	0.000426	CcSEcCtD
Melatonin—Infection—Doxorubicin—lung cancer	4.02e-05	0.000425	CcSEcCtD
Melatonin—Pain—Methotrexate—lung cancer	3.99e-05	0.000422	CcSEcCtD
Melatonin—Shock—Doxorubicin—lung cancer	3.98e-05	0.000421	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—lung cancer	3.96e-05	0.000419	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—lung cancer	3.96e-05	0.000419	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—lung cancer	3.93e-05	0.000415	CcSEcCtD
Melatonin—Nausea—Docetaxel—lung cancer	3.85e-05	0.000407	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—lung cancer	3.82e-05	0.000404	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—lung cancer	3.69e-05	0.00039	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.68e-05	0.00039	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—lung cancer	3.66e-05	0.000387	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—lung cancer	3.63e-05	0.000384	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—lung cancer	3.59e-05	0.00038	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—lung cancer	3.56e-05	0.000376	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—lung cancer	3.49e-05	0.000369	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—lung cancer	3.48e-05	0.000369	CcSEcCtD
Melatonin—Pain—Doxorubicin—lung cancer	3.46e-05	0.000366	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—lung cancer	3.44e-05	0.000364	CcSEcCtD
Melatonin—Asthenia—Methotrexate—lung cancer	3.35e-05	0.000354	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—lung cancer	3.31e-05	0.00035	CcSEcCtD
Melatonin—Pruritus—Methotrexate—lung cancer	3.3e-05	0.000349	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—lung cancer	3.2e-05	0.000338	CcSEcCtD
Melatonin—Dizziness—Methotrexate—lung cancer	3.09e-05	0.000327	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—lung cancer	2.98e-05	0.000315	CcSEcCtD
Melatonin—Vomiting—Methotrexate—lung cancer	2.97e-05	0.000314	CcSEcCtD
Melatonin—Rash—Methotrexate—lung cancer	2.94e-05	0.000311	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—lung cancer	2.94e-05	0.000311	CcSEcCtD
Melatonin—Headache—Methotrexate—lung cancer	2.92e-05	0.000309	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—lung cancer	2.9e-05	0.000307	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—lung cancer	2.86e-05	0.000303	CcSEcCtD
Melatonin—Nausea—Methotrexate—lung cancer	2.77e-05	0.000293	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—lung cancer	2.67e-05	0.000283	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—lung cancer	2.57e-05	0.000272	CcSEcCtD
Melatonin—Rash—Doxorubicin—lung cancer	2.55e-05	0.00027	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—lung cancer	2.55e-05	0.000269	CcSEcCtD
Melatonin—Headache—Doxorubicin—lung cancer	2.53e-05	0.000268	CcSEcCtD
Melatonin—Nausea—Doxorubicin—lung cancer	2.4e-05	0.000254	CcSEcCtD
Melatonin—CALM3—Immune System—NRAS—lung cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—lung cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—lung cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—lung cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—lung cancer	1.26e-06	1.1e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EP300—lung cancer	1.25e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EP300—lung cancer	1.25e-06	1.1e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6R—lung cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6R—lung cancer	1.25e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CREBBP—lung cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CREBBP—lung cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—lung cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAP2K1—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—POMC—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—lung cancer	1.23e-06	1.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—lung cancer	1.22e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—lung cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EP300—lung cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EP300—lung cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—lung cancer	1.21e-06	1.06e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—lung cancer	1.2e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CREBBP—lung cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—lung cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—lung cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—lung cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAP2K1—lung cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAP2K1—lung cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—lung cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—lung cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—lung cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—lung cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—lung cancer	1.18e-06	1.03e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—lung cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—lung cancer	1.17e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—lung cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—lung cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—lung cancer	1.15e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—lung cancer	1.13e-06	9.95e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—lung cancer	1.13e-06	9.95e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—lung cancer	1.13e-06	9.93e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—lung cancer	1.13e-06	9.93e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—lung cancer	1.13e-06	9.93e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—lung cancer	1.12e-06	9.86e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—lung cancer	1.12e-06	9.83e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—POMC—lung cancer	1.12e-06	9.81e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—lung cancer	1.12e-06	9.81e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—lung cancer	1.12e-06	9.8e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—lung cancer	1.12e-06	9.8e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOA1—lung cancer	1.1e-06	9.64e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—lung cancer	1.1e-06	9.63e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—lung cancer	1.1e-06	9.62e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—lung cancer	1.09e-06	9.59e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—lung cancer	1.09e-06	9.58e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—lung cancer	1.09e-06	9.57e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—lung cancer	1.09e-06	9.56e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CREBBP—lung cancer	1.09e-06	9.55e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RAF1—lung cancer	1.09e-06	9.55e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—lung cancer	1.08e-06	9.51e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—lung cancer	1.08e-06	9.51e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—lung cancer	1.08e-06	9.45e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—lung cancer	1.07e-06	9.38e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—lung cancer	1.07e-06	9.35e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—lung cancer	1.06e-06	9.32e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—lung cancer	1.06e-06	9.32e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—lung cancer	1.06e-06	9.32e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—lung cancer	1.06e-06	9.32e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—lung cancer	1.06e-06	9.31e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—lung cancer	1.06e-06	9.31e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—lung cancer	1.06e-06	9.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—lung cancer	1.06e-06	9.27e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—lung cancer	1.06e-06	9.26e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—lung cancer	1.06e-06	9.26e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—lung cancer	1.05e-06	9.25e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—lung cancer	1.05e-06	9.25e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RAF1—lung cancer	1.05e-06	9.24e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RAF1—lung cancer	1.05e-06	9.24e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.05e-06	9.23e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—EP300—lung cancer	1.05e-06	9.19e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—lung cancer	1.04e-06	9.14e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—lung cancer	1.04e-06	9.14e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—lung cancer	1.04e-06	9.14e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—lung cancer	1.03e-06	9.06e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—lung cancer	1.03e-06	9.05e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—lung cancer	1.03e-06	9.05e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—lung cancer	1.03e-06	9.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—lung cancer	1.03e-06	9.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—lung cancer	1.03e-06	9.02e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—lung cancer	1.03e-06	9.02e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—lung cancer	1.02e-06	8.96e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—lung cancer	1.02e-06	8.94e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—lung cancer	1.01e-06	8.9e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—EP300—lung cancer	1.01e-06	8.89e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—EP300—lung cancer	1.01e-06	8.89e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—lung cancer	1.01e-06	8.88e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—lung cancer	1.01e-06	8.86e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—lung cancer	1.01e-06	8.83e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—lung cancer	1e-06	8.8e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—lung cancer	1e-06	8.79e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—EP300—lung cancer	9.94e-07	8.72e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—lung cancer	9.88e-07	8.67e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—lung cancer	9.88e-07	8.67e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—lung cancer	9.87e-07	8.66e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—lung cancer	9.82e-07	8.61e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—lung cancer	9.82e-07	8.61e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—lung cancer	9.78e-07	8.58e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—lung cancer	9.78e-07	8.58e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—lung cancer	9.76e-07	8.56e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—lung cancer	9.75e-07	8.56e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—lung cancer	9.74e-07	8.55e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—lung cancer	9.74e-07	8.55e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—lung cancer	9.71e-07	8.52e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—lung cancer	9.7e-07	8.5e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—lung cancer	9.7e-07	8.5e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—POMC—lung cancer	9.55e-07	8.38e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—lung cancer	9.52e-07	8.35e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—lung cancer	9.5e-07	8.33e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—lung cancer	9.46e-07	8.3e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—lung cancer	9.46e-07	8.3e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—lung cancer	9.44e-07	8.28e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—lung cancer	9.44e-07	8.28e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—lung cancer	9.4e-07	8.24e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—lung cancer	9.4e-07	8.24e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CREBBP—lung cancer	9.31e-07	8.16e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—lung cancer	9.28e-07	8.14e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—lung cancer	9.27e-07	8.13e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—lung cancer	9.25e-07	8.12e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—lung cancer	9.24e-07	8.1e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—lung cancer	9.21e-07	8.07e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—lung cancer	9.21e-07	8.07e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—lung cancer	9.21e-07	8.07e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—lung cancer	9.19e-07	8.06e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—lung cancer	9.19e-07	8.06e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—lung cancer	9.19e-07	8.06e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—lung cancer	9e-07	7.89e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—lung cancer	8.98e-07	7.88e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—lung cancer	8.97e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—lung cancer	8.97e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—lung cancer	8.96e-07	7.86e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—lung cancer	8.95e-07	7.85e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—lung cancer	8.95e-07	7.85e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—lung cancer	8.94e-07	7.84e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—lung cancer	8.94e-07	7.84e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—lung cancer	8.92e-07	7.82e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—lung cancer	8.91e-07	7.81e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—lung cancer	8.91e-07	7.81e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—lung cancer	8.89e-07	7.79e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—lung cancer	8.89e-07	7.79e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—lung cancer	8.88e-07	7.78e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—lung cancer	8.82e-07	7.74e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EP300—lung cancer	8.76e-07	7.68e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—lung cancer	8.71e-07	7.64e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—lung cancer	8.67e-07	7.6e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—lung cancer	8.67e-07	7.6e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—lung cancer	8.59e-07	7.53e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—lung cancer	8.59e-07	7.53e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—lung cancer	8.59e-07	7.53e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—lung cancer	8.56e-07	7.51e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—lung cancer	8.53e-07	7.48e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—lung cancer	8.52e-07	7.47e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EP300—lung cancer	8.47e-07	7.43e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EP300—lung cancer	8.47e-07	7.43e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—lung cancer	8.3e-07	7.28e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—lung cancer	8.28e-07	7.26e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—lung cancer	8.28e-07	7.26e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—lung cancer	8.24e-07	7.23e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—lung cancer	8.24e-07	7.23e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—lung cancer	8.22e-07	7.21e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—lung cancer	8.22e-07	7.21e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—lung cancer	8.2e-07	7.19e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—lung cancer	8.19e-07	7.19e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—lung cancer	8.19e-07	7.18e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—EP300—lung cancer	8.13e-07	7.13e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—lung cancer	8.03e-07	7.04e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—lung cancer	8.03e-07	7.04e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—lung cancer	7.95e-07	6.97e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—lung cancer	7.95e-07	6.97e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—lung cancer	7.93e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—lung cancer	7.93e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—lung cancer	7.93e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—lung cancer	7.93e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—lung cancer	7.92e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—lung cancer	7.92e-07	6.95e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—lung cancer	7.85e-07	6.88e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—lung cancer	7.78e-07	6.82e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—lung cancer	7.75e-07	6.8e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—lung cancer	7.69e-07	6.75e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—lung cancer	7.63e-07	6.7e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—lung cancer	7.62e-07	6.68e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—lung cancer	7.59e-07	6.66e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—lung cancer	7.59e-07	6.66e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—lung cancer	7.58e-07	6.65e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—lung cancer	7.56e-07	6.63e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—lung cancer	7.5e-07	6.58e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—lung cancer	7.5e-07	6.58e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—lung cancer	7.47e-07	6.55e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—EP300—lung cancer	7.42e-07	6.51e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—lung cancer	7.38e-07	6.48e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—lung cancer	7.38e-07	6.48e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—lung cancer	7.35e-07	6.45e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—lung cancer	7.31e-07	6.41e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—lung cancer	7.31e-07	6.41e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—lung cancer	7.22e-07	6.33e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—lung cancer	7.22e-07	6.33e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—lung cancer	7.05e-07	6.19e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—lung cancer	6.82e-07	5.98e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—lung cancer	6.82e-07	5.98e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—lung cancer	6.65e-07	5.83e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—lung cancer	6.48e-07	5.68e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—EP300—lung cancer	6.34e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—lung cancer	6.33e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—lung cancer	6.27e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—lung cancer	6.27e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—lung cancer	6.27e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—lung cancer	6.12e-07	5.37e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—lung cancer	6.12e-07	5.37e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—lung cancer	6.06e-07	5.32e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—lung cancer	6.06e-07	5.32e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—lung cancer	6.02e-07	5.28e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—lung cancer	6.01e-07	5.27e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—lung cancer	6e-07	5.26e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—lung cancer	5.8e-07	5.09e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—lung cancer	5.8e-07	5.09e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—lung cancer	5.74e-07	5.03e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—lung cancer	5.55e-07	4.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—lung cancer	5.55e-07	4.87e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—lung cancer	5.49e-07	4.81e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—lung cancer	5.29e-07	4.64e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—lung cancer	5.12e-07	4.49e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—lung cancer	5.12e-07	4.49e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—lung cancer	4.92e-07	4.31e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—lung cancer	4.69e-07	4.11e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—lung cancer	4.48e-07	3.93e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—lung cancer	3.83e-07	3.36e-06	CbGpPWpGaD
